The relationship between adipokines, osteocalcin and bone quality in chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 24, Issue 10, 2009, Pages 3120-3125

  Bacchetta, Justine ^a,b,c   Boutroy, Stéphanie ^b,c   Guebre Egziabher, Fitsum ^b,c,d   Juillard, Laurent ^b,c,d   Drai, Jocelyne ^b,c   Pelletier, Solenne ^b,d   Richard, Michel ^b,c   Charrié, Anne ^b,c,e   Carlier, Marie Christine ^b,c   Chapurlat, Roland ^b,c   Laville, Maurice ^b,c,d   Fouque, Denis ^b,c,d  

^a Hôpital Femme Mre Enfant   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c UNIVERSITÉ DE LYON   (France)

^d EDOUARD HERRIOT HOSPITAL   (France)

^e UNIVERSITÉ CLAUDE BERNARD LYON 1   (France)

Author keywords

Adiponectin; Bone imaging; Chronic kidney disease; HR pQCT; Osteocalcin

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CALCIUM; LEPTIN; OSTEOCALCIN; VITAMIN D;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BONE DENSITY; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; KIDNEY CORTEX; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; THICKNESS; THREE DIMENSIONAL IMAGING; TIBIA; TRABECULAR BONE; UNIVARIATE ANALYSIS; VITAMIN SUPPLEMENTATION;

ADIPONECTIN; AGED; BONE DENSITY; CHRONIC DISEASE; HUMANS; KIDNEY DISEASES; LEPTIN; OSTEOCALCIN; PROSPECTIVE STUDIES;

EID: 70349492442     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp262     Document Type: Article

References (28)

1. Chenu C, Colucci S, Grano M et al. Osteocalcin induces chemo-taxis, secretion of matrix proteins, and calcium-mediated intracellular signaling in human osteoclast-like cells. J Cell Biol 1994; 127: 1149-1158
2. Lee NK, Sowa H, Hinoi E et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007; 130: 456-469
3. Ferron M, Hinoi E, Karsenty G et al. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 2008; 105: 5266-5270
4. Ducy P, Desbois C, Boyce B et al. Increased bone formation in osteocalcin-deficient mice. Nature 1996; 382: 448-452
5. Yamada S, Inaba M, Kurajoh M et al. Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction. Clin Endocrinol (Oxf) 2008; 69: 189-196
6. Guebre-Egziabher F, Drai J, Fouque D. Adiponectin and chronic kidney disease. J Ren Nutr 2007; 17: 9-12
7. Yamauchi T, Kamon J, Ito Y et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003; 423: 762-769
8. Guebre-Egziabher F, Bernhard J, Funahashi T et al. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. Nephrol Dial Transplant 2005; 20: 129-134
9. Zoccali C, Mallamaci F, Tripepi G et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002; 13: 134-141 (Pubitemid 34042020)
10. Iwashima Y, Horio T, Kumada M et al. Adiponectin and renal function, and implication as a risk of cardiovascular disease. Am J Cardiol 2006; 98: 1603-1608
11. Nishimura M, Hashimoto T, Kobayashi H et al. Association of the circulating adiponectin concentration with coronary in-stent restenosis in haemodialysis patients. Nephrol Dial Transplant 2006; 21: 1640-1647
12. Ohashi N, Kato A, Misaki T et al. Association of serum adiponectin levels with all-cause mortality in hemodialysis patients. Intern Med 2008; 47: 485-491
13. Menon V, Li L, Wang X et al. Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol 2006; 17: 2599-2606 (Pubitemid 44300977)
14. Kollerits B, Fliser D, Heid IM et al. Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study. Kidney Int 2007; 71: 1279-1286 (Pubitemid 46884246)
15. Richards JB, Valdes AM, Burling K et al. Serum adiponectin and bone mineral density in women. J Clin Endocrinol Metab 2007; 92: 1517-1523
16. KanazawaI,YamaguchiT,YamamotoM et al. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab 2009; 94: 45-49
17. Boutroy S, Bouxsein ML, Munoz F et al. In vivo assessment of trabec-ular bone microarchitecture by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab 2005; 90: 6508-6515
18. Bacchetta J, Boutroy S, Juillard L et al. Bone imaging and chronic kidney disease: will high resolution peripheral quantitative computed tomography improve bone evaluation and therapeutic management? J Ren Nutr 2009; 19: 44-49
19. Yaturu S, Reddy RD, Rains J et al. Plasma and urine levels of resistin and adiponectin in chronic kidney disease. Cytokine 2007; 37: 1-5
20. Zoccali C, Panuccio V, Tripepi G et al. Leptin and biochemical markers of bone turnover in dialysis patients. J Nephrol 2004; 17: 253-260
21. Coen G, Ballanti P, Fischer MS et al. Serum leptin in dialysis renal osteodystrophy. Am J Kidney Dis 2003; 42: 1036-1042
22. Luo XH, Guo LJ, Yuan LQ et al. Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp Cell Res 2005; 309: 99-109
23. Kanazawa I, Yamaguchi T, Yano S et al. Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells. BMC Cell Biol 2007; 8: 51
24. Yamaguchi N, Kukita T, Li YJ et al. Adiponectin inhibits induction of TNF-alpha/RANKL-stimulated NFATc1 via the AMPK signaling. FEBS Lett 2008; 582: 451-456
25. Jurimae J, Jurimae T. Plasma adiponectin concentration in healthy pre-and postmenopausal women: relationship with body composition, bone mineral, and metabolic variables. Am J Physiol Endocrinol Metab 2007; 293: E42-E47
26. Peng XD, Xie H, Zhao Q et al. Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. Clin Chim Acta 2008; 387: 31-35
27. Tamura T, Yoneda M, Yamane K et al. Serum leptin and adiponectin are positively associated with bone mineral density at the distal radius in patients with type 2 diabetes mellitus. Metabolism 2007; 56: 623-628
28. Rosen CJ, Bouxsein ML. Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol 2006; 2: 35-43